Associations of HLA-A, -B and-DRB1 Types with Oral Diseases in Swiss Adults by Mauramo, Matti et al.
Associations of HLA-A, -B and -DRB1 Types with Oral
Diseases in Swiss Adults
Matti Mauramo1,2*, Adrian Markus Ramseier1, Andreas Buser3, Jean-Marie Tiercy4, Roland Weiger5,
Tuomas Waltimo1
1Department of Preventive Dentistry and Oral Microbiology, School of Dental Medicine, University of Basel, Basel, Switzerland, 2 Institute of Dentistry, University of
Helsinki, Helsinki, Finland, 3 The Blood Transfusion Service SRC Basel, Basel, Switzerland, 4National Reference Laboratory for Histocompatibility, Geneva University
Hospital and University of Geneva, Geneva, Switzerland, 5Clinic for Periodontology, Endodontology and Cariology, School of Dental Medicine, University of Basel, Basel,
Switzerland
Abstract
Human leukocyte antigens (HLA) are crucial components of host defense against microbial challenge but the associations of
HLA types with oral infectious diseases have not been studied in detail. This prospective cross-sectional study examined
associations of HLA-A, -B and -DRB1 types with common oral diseases in a healthy Swiss adult population. 257 subjects
(107 m, 150 f, mean age: 43.5 yr; range: 21–58 yr) with known HLA-A, -B and -DRB1 profiles and comprehensive medical
records were included. A thorough anamnesis was followed by oral examinations including saliva flow measurements, the
DMFT score for cariological status, complete periodontal status with plaque and bleeding indexes as well as assessment of
mucosal alterations and temporomandibular dysfunction (TMD). Student’s t-test and Pearson chi-square test were utilized
to compare the oral diseases between HLA positive and negative subjects. Bonferroni correction for multiple comparisons
was used and PBonf,0.05 was considered statistically significant. HLA types -B15 (PBonf = 0.002), -B51 (PBonf = 0.02) and -
DRB1*12 (PBonf = 0.02) were associated with less periodontal disease manifestations. HLA-A32 had a positive association
with TMD dysfunction (PBonf = 0.012). No other statistically significant associations were observed. In conclusion, HLA types
may contribute to the development of oral diseases in generally healthy Caucasian adults.
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Introduction
Major histocompatibility complex (MHC) class I and II
molecules, called human leukocyte antigens (HLA), have a pivotal
role in immune response [1] [2] [3]. Pathogen-derived antigens
are recognized by T-cells in the form of peptides that are bound to
HLA molecules after antigen processing. HLA molecules vary
extensively between individuals which may explain differences in
inflammatory response towards microbial challenge [3] [4] [5] [6]
[7]. However, the associations of HLA class I (HLA-A, -B and -C)
and II antigens (HLA-DR, -DQ and -DP) with oral infectious
diseases have not been studied extensively. Particularly, studies on
possible HLA associations among generally healthy subjects are
scarce.
Previously, associations have been documented between HLA
antigens and periodontitis [8] [9] [10] [11]. A meta-analysis
reported HLA class I types HLA-A9 and -B15 to indicate
susceptibility to aggressive periodontitis, whereas HLA-A2 and -B5
were potential protective factors against aggressive periodontitis
[12]. However, evidence on the associations of HLA types with
dental caries is lacking. Contrasting results have been obtained on
the associations of HLA class II antigens with salivary counts of
cariogenic microbes, or with DMFT/S (decayed, missing or filled
tooth/surface) score [11] [13] [14] [15] [16] [17] [18]. Among
severely ill hemato-oncological patients prior to bone marrow
transplantation we have observed an association of increased
caries prevalence with the HLA types -A32, -B5, and -DR2, and
a lower prevalence in HLA-B35 and -C4-positive individuals
[10].
Hitherto, studies concerning the association of HLA types with
oral diseases including caries and peridontitis have been based on
a limited number of subjects or only on particular patient or
population groups such as children or medically compromised
sub-populations. Thus, these studies are not representative of
generally healthy Caucasian adult populations. In addition,
mucosal alteration, temporomandibular joint dysfunction (TMD)
and saliva have not been subjected to epidemiological analyses in a
sufficient scale. An objective of this preliminary study was to
investigate associations of class I HLA-A and -B and class II HLA–
DRB1 types with a broad range of oral diseases including
periodontitis, caries, TMD and mucosal alteration as well as saliva
flow in a population of healthy Swiss adults. Furhermore, this
study was aimed to be an exploratory study without HLA-type-
specific hypothesis.
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Subjects and Methods
Ethics Statement
This prospective cross-sectional clinical study has been con-
ducted according to the principles expressed in the Declaration of
Helsinki, and has been approved by the Ethics Committee of
Basel, Switzerland. Written informed consent was obtained from
each subject.
Subjects and HLA typing
Between 2009 and 2011, 2000 invitations were sent to
consecutive subjects of the Swiss bone marrow donor register of
Basel. 257 subjects volunteered to participate in the study. For the
bone marrow donor register, the HLA types of the participants
were already determined as follows: 1. HLA-A and -B types were
determined by serology, i.e. by microlymphocytotoxicity using the
Biotest AB120 trays (Biotest AG, Dreieich, Germany). 2. HLA-
DRB1 types were obtained by PCR-sequence-specific oligonucle-
otide probe hybridization using commercial reagents (bioMe´rieux,
Lyon, and One Lambda, Ingen, France). Because the majority of
donors included in the study had been tested by DRB1 generic
typing only, only low resolution level data were considered for the
present analysis. Because of the very low antigen frequencies the
DRB1*09, *10 and *16 allotypes were not computed in the final
data analysis. Similarly the HLA-A (A25, A30, A33, A34, A66,
A74) and HLA-B (B45, B46, B47, B48, B50, B52, B53, B54, B56,
B58, B59, B61, B63, B67, B70, B73, B75, B76, B77, B78, B81,
B82) antigens assigned with a low frequency or absent in the study
group were not included in the analysis.
Anamnesis included oral hygiene (tooth brushing and flossing
frequency) and dietary habits (frequency of eating sweets and/or
confectionary), tobacco smoking (current, former, never), presence
of chronic diseases and the use of any pharmaceutical products.
Oral examinations
The clinical oral examinations of the patients were carried out
by two calibrated clinicians (MM 204 subjects; AR 51 subjects).
The recordings of the DMFT score for cariological status, mucosal
alterations and temporomandibular dysfunction (TMD) followed
the guidelines for oral health surveys of WHO [19]. In addition, a
complete clinical periodontal status including probing pocket
depth (PD) and clinical attachment level measurement (CAL) from
six sites/tooth was performed with a pressure calibrated
periodontal probe [20]. Oral hygiene was assessed by dental
plaque present or not, according to O’Leary’s plaque control
record [21] and bleeding on periodontal probing present or not,
according to Ainamo and Bay [22]. Stimulated whole saliva flow
rate (SWSFR) was determined as described by Sreebny and
Vissink [23]. Briefly, subjects were asked to chew a commercially
available, individually packed, neutral piece of paraffin wax
(0.9 g/wax; Orion Diagnostica, Espoo, Finland) for one minute
while swallowing all the saliva, followed by a five-minute period of
chewing a new piece of wax and collecting the produced saliva in a
graduated (mL) test tube (Sarstedt, Nu¨mbrecht, Germany).
Statistical methods
In all groups, HLA type frequencies were determined by
counting the subjects being positive for a certain HLA allele. Mean
6 standard deviation (SD) and 95% confidence intervals (CI) were
calculated for metric variables. To ensure normal distribution only
HLA types having .10 subjects were analyzed and the equality of
variances was confirmed by the Levene’s test. Student’s t-test was
performed for bivariate comparison between HLA positive and
negative subjects. For dichotomous variables Pearson chi-square
test was utilized. To determine statistical significance the
Bonferroni correction for multiple comparisons was used ( = PBonf),
and PBonf,0.05 was considered as statistically significant.
Results
The subjects (107 m, 150 f, mean age: 43.5 yr; range: 21–58 yr)
represented a generally healthy Swiss adult population with few
self-reported medications (mean: 0.5, SD: 1.0, range: 0–10). 15%
of the subjects were current, 27% former and 58% never smokers.
Oral hygiene habits were generally good as 81% of the subjects
reported brushing two or more times a day. However, relatively
popular was also eating sweets and/or confectionary, as 42%
reported consuming them more than 5 times a day and 51% 1–5
times/week (Detailed information of oral health related habits are
shown in supportive information (Table S1)). The order of relative
proportions of the most common HLA types (HLA-A01, -A02, -
A03, -B07, -B35, -B44, -DRB1*01, -DRB1*04, -DRB1*07 and
DRB1*13) was similar to a previous report in German-speaking
Swiss population [24], suggesting our sample to be representative
of this population. (For HLA frequencies, please see supportive
information (Table S1); The original data available as supportive
information (Table S2)).
DMFT
No statistically significant associations of HLA-A, -B or -DRB1
alleles with DMFT score were found. HLA-A1 positive subjects
were observed to have a tendency towards lower DMFT (mean
DMFT: 12.965.5) compared to HLA-A1 negative subjects (mean
DMFT: 14.967.0; P = 0.03, PBonf = n.s.,) However, after Bonfer-
roni correction, the effect was not statistically significant (Table 1).
Periodontal status
Less clinical attachment loss (CAL) was observed among
subjects with HLA-B15 (mean number of sites with CAL $
6 mm: 0.260.6; PBonf,0.01) and HLA-DRB1*12 (mean number
of sites with CAL $6 mm: 0.360.6; PBonf = 0.02) compared with
the respective HLA type negative subjects (mean CAL $6 mm:
1.363.7; and 1.263.5, respectively). In addition, HLA-B40, -
DRB1*01 and -DRB1*13 positive subjects had less clinical
attachment loss of $4 mm and/or $6 mm compared with the
respective HLA type negative subjects (Table 2). However, after
the Bonferroni correction the differences were statistically not
significant.
HLA-B51 was associated with shallower probing pocket depths
(PD). Subjects with HLA-B51 had fewer periodontal pockets of $
6 mm (mean number of pockets: 0.260.6; PBonf = 0.02) compared
with HLA-B51-negative subjects (mean: 1.163.3). In addition,
HLA-B62 and -DRB1*13 positive subjects had fewer deep
periodontal pockets ($4 mm and/or $6 mm) compared with
the respective HLA type negative subjects. However, after the
Bonferroni correction the differences were statistically not
significant.
There were no differences in the indexes of periodontal health
(papillary bleading index, bleeding on probing) between the HLA
types (Table 2).
Other oral diseases and conditions
HLA-A32 positive subjects had clicking in temporomandibular
joint (TMJ) more frequently than HLA-A32 negative subjects
(40.7% vs. 17.6%, P=0.001, PBonf = 0.012). Clinical TMJ clicking,
diagnosed according to WHO criteria [19], was also more
prevalent in HLA-B14 positive subjects but this difference was
not statistically significant (P = 0.042, PBonf = n.s.) (Table 1).
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No statistically significant associations of HLA-A, -B or -DRB1
alleles with mucosal alterations were found. HLA-A29 increased
the prevalence of mucosal alteration diagnosed according to the
criteria of WHO, but this difference was not statistically significant
(P = 0.012, PBonf = n.s.) (Table 1).
Stimulated whole saliva flow rates did not differ between the
HLA types (Table 1).
Discussion
This prospective clinical study examined associations of HLA-A,
-B and -DRB1 types with oral diseases in a generally healthy Swiss
adult population. The study focused particularly on the two most
prevalent oral diseases, caries and peridontitis. In addition,
temporomandibular dysfunctions, mucosal alterations as well as
saliva flow rates were examined.
DMFT index was used to determine past and present need for
cariological interventions. In previous studies, associations be-
tween HLA types and caries have been somewhat inconsistent.
The earliest study observed HLA-DR4 to be associated with
dental caries [8]. Later, HLA-DR4 has been shown to be
associated also with early childhood caries [18]. A few studies
have examined associations between HLA-DR4 and saliva levels
of Streptococcus mutans with contrasting results [13] [14] [15]
[17]. In our previous study, we observed a weak association
between HLA-DR2 and an increased DMFT score among
recipients of hematopoietic stem cell transplantation [10]. In
addition, HLA class I antigens -A32, -B5 and -B35 were observed
to be associated with altered DMFT [10]. In contrast, studies
conducted among generally healthy African-American women
(n= 186), young Japanese adults (n = 106) and a child population
(n= 60) have failed to demonstrate associations of HLA class II
antigens with DMFT/S score [11] [16] [17]. Our current results
are in line with these later studies, since no statistically significant
association of altered DMFT with any of the HLA-A, -B or -DRB1
types could be detected in the population of Caucasian adults.
HLA-A1 may have a negative correlation with DMFT but this
was, however, not confirmed after applying the Bonferroni
correction. Altogether, caries is an example of a disease with
multiple etiological factors including dietary and oral hygiene
habits, mutans streptococci colonisation, strain virulence factors
and oral saliva-associated defense mechanisms. Therefore, a
strong association of any of the HLA types with caries would
have been surprising.
Contrary to the etiology of caries, several host dependent but
not acquired factors are considered to contribute to periodontal
diseases. Studies have been conducted to identify HLA types that
predispose patients to periodontal destruction, with varying results.
A meta-analysis by Stein et al. found no associations between HLA
types and chronic periodontitism [12]. However, in that study a
positive association of HLA-B15 with aggressive periodontitis was
observed. No aggressive periodontitis was seen in our study, but
HLA-B15 positive subjects had less clinical attachment loss
compared with HLA-B15 negative subjects. This partly contro-
versial observation demonstrates better periodontal health of
HLA-B15 positive subjects over a long period of time, as CAL
measurement is not interfered by temporary and local irritation,
hormonal factors or lack of dental treatment as readily as
periodontal pocket depth measurements (PD). In the light of these
studies, it seems that HLA-B15 positive subjects have a somewhat
peculiar genetic response towards periodontal challenge, having
mainly a high tolerance against microbes but being prone to
aggressive forms of periodontitis. In the current study, also novel
negative associations of HLA-B51 and -DRB1*12 with periodon-
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tal disease manifestations were observed. These observations
warrant further studies. In addition, we can not exclude that the
primary HLA association is with HLA-C alleles that are in
preferential linkage disequilibrium with -B51, such as -C*14 and
-C*15.
HLA types contribute to the development of rheumatic diseases
and arthritis. For example, HLA-B27 is routinely used in
diagnostics due to its close association with ankylosing spondylitis
and spondyloarthropathy [25] [26]. Bacterial contamination has
been suggested to be one possible mechanism for HLA contribu-
tion to temporomandibular dysfuction (TMD) [27]. Different
bacteria including Chlamydia trachomatis, Mycoplasma genitalium,
and other Mycoplasma species have been identified within
temporomandibular joint synofial fluid and surrounding tissues
[28] [29]. Two studies have been conducted to analyze the
associations of HLA types with temporomandibular dysfunction
(TMD). In patients with rheumatic diseases together with TMD
and in patients with severe TMD several HLA-A, -B and -DR
alleles have been found in increased frequency [27] [30]. In this
study, subjective TMD symptoms, mouth opening and ‘clicking’ as
a sign of TMD were recorded. Similarly to the previous studies,
clicking in the temporomandibular joint was more prevalent in
HLA-B14 positive subjects but this difference was not statistically
significant. In addition, HLA-A32 positive subjects had clicking in
the temporomandibular joint statistically significant more fre-
quently than HLA-A32 negative subjects. No associations of HLA-
A32 with TMD have been reported previously. However, due to
the limited number of subjects with this symptom and respective
ethical considerations, painless clicking was not further examined
by radiological methods, but warrants further studies.
HLA molecules have also been associated with inflammatory
diseases causing oral and gastrointestinal ulcers. HLA-B51 has
been strongly associated with Bechet’s syndrome and recurrent
oral ulcers [31] [32] [33]. In addition, HLA-DR8 has been
associated with treatment resistant Crohn’s disease. In this study,
any signs of oral mucosal lesions including ulcers, leukoplakia,
lichen planus, absesses or other conditions were examined.
However, no statistically significant associations of HLA-A, -B or
-DR types with mucosal alterations could be detected.
In terms of subjects and scope, the current study is the most
extensive that has been conducted in the field. In addition, the
results can be considered representative of Swiss population, as the
observed HLA frequencies resembled those previously reported in
Swiss population [23]. However, the study has limitations due to
both the diversity of HLA molecules in the investigated population
and the confounding factors of the multicausal oral diseases. Thus,
this study should be considered as a preliminary report on
associations between HLA types and oral diseases, relying to
clinical parameters globally recommended by the WHO and other
international organisations for the screening of caries and
periodontal diseases. However, when assessing the complex and
delicate responses of host to infections, more sensitive measures
might be useful. Consequently, this study warrants further
analyzes of saliva and gingival crevicular fluid samples of the
subjects to determinate the microbes and host immune responses
in terms of matrix metalloproteinases and tissue inhibitory
proteinases capable of predisposing to the common oral diseases.
In addition, we aim to rescreen the subjects in 5 years using the
present data as a basis for a longitudinal study design to define the
disease progression affected by HLA type dependent host
response.
In conclusion, the findings of this hitherto largest study are in
line with most of the previous publications concerning caries and
periodontitis, as HLA types had only limited associations with the
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prevalence of these diseases in a population of generally healthy
adults. With regard to temporomandibular dysfunctions and
mucosal lesions, the current study could not confirm the previously
suggested associations of HLA types with the diseases. However,
the present study found HLA types which may contribute to oral
diseases among healthy adults. These include HLA-A1 in caries,
HLA-B15, -B51 and -DRB1*12 in periodontitis and HLA-A32 in
temporomandibular dysfunctions. The exact role and mechanisms
of the HLA types in oral diseases still remain for exploration in
future studies.
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